Fuente: PubMed "royal jelly" J Cosmet Dermatol. 2025 Oct;24(10):e70503. doi: 10.1111/jocd.70503.ABSTRACTBACKGROUND: No clinical trials have reported on the wrinkle-improving effects of cosmetics which activate stem cells in vitro.AIMS: To evaluate the anti-wrinkle effects of protease-treated royal jelly (pRJ)-containing cream application to the skin.MATERIALS & METHODS: Seventy healthy Japanese women concerned about skin aging were treated with pRJ-containing cream or placebo for 12 weeks using the split-face method in a placebo-controlled, double-blind, parallel-group study.RESULTS: The pRJ-containing cream group showed an improvement in the maximum depth and average depth of the biggest wrinkle in the crow's feet wrinkle, along with increased water content of the stratum corneum and dermal thickness, compared to the placebo group. Significant decreases in the relative amount of bacterial microbiome of the cheeks were observed only in the pRJ-containing cream group. In the ex vivo study, expression of COL17A1, epidermal stem cell function marker, was significantly up-regulated with the use of the pRJ-containing cream compared with the placebo cream.CONCLUSION: This is the first study to demonstrate the wrinkle-improving effects of pRJ. Our results suggest that pRJ not only controls stratum corneum water content, dermal thickness, and bacterial microbiome, but also affects stem cell competition and mesenchymal stem cell activation. pRJ can reduce or eliminate certain skin concerns of women by improving age-related wrinkles.PMID:41134061 | PMC:PMC12551441 | DOI:10.1111/jocd.70503